The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
LAVA Therapeutics N.V.(NASDAQ:LVTX) 
Lava Therapeutics B.V., a biotechnology company, engages in developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its platform. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/...
Share this website to your friends
LAVA Therapeutics N.V. Days Payable Outstanding ttm (DPO)
LAVA Therapeutics N.V. Days Receivable Outstanding ttm (DSO)
LAVA Therapeutics N.V. Days Inventory Outstanding ttm (DIO)
LAVA Therapeutics N.V. Op Cashflow Per Share ttm
LAVA Therapeutics N.V. Free Cashflow Per Share ttm
LAVA Therapeutics N.V. Cash Per Share ttm
LAVA Therapeutics N.V. P/S ratio ttm
LAVA Therapeutics N.V. (GAAP) P/E ratio ttm
LAVA Therapeutics N.V. P/B ratio ttm
No extra charts and metrics for this ticker.